Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Glennerster

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|May 14, 2016
CONFLICT. Reconciliation in Sierra LeoneKatherine Casey, Rachel Glennerster
Fortune|January 11, 2005
A magnet for vaccinesMichael Kremer, Rachel Glennerster
Science (New York, N.Y.)|April 20, 2013
The challenge of education and learning in the developing worldMichael Kremer, Conner Brannen, Rachel Glennerster
Plos One|November 2, 2016
Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled TrialShama Mohammed, Rachel Glennerster, Aamir J Khan
Journal of the European Economic Association|September 28, 2011
PUTTING A BAND-AID ON A CORPSE: INCENTIVES FOR NURSES IN THE INDIAN PUBLIC HEALTH CARE SYSTEMAbhijit V Banerjee, Rachel Glennerster, Esther Duflo
BMJ (Clinical Research Ed.)|May 19, 2010
Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentivesAbhijit Vinayak Banerjee, Esther Duflo, Rachel Glennerster, et al.
The American Economic Review|December 26, 2025
A Signal to End Child Marriage: Theory and Experimental Evidence from Bangladesh<sup>†</sup>Nina Buchmann, Erica Field, Rachel Glennerster, et al.
Eclinicalmedicine|July 5, 2022
Small mobile conditional cash transfers (mCCTs) of different amounts, schedules and design to improve routine childhood immunization coverage and timeliness of children aged 0-23 months in Pakistan: An open label multi-arm randomized controlled trialSubhash Chandir, Danya Arif Siddiqi, Sara Abdullah, et al.
Health Economics|October 3, 2006
Advance market commitments for vaccines against neglected diseases: estimating costs and effectivenessErnst R Berndt, Rachel Glennerster, Michael R Kremer, et al.
Science (New York, N.Y.)|February 26, 2021
Market design to accelerate COVID-19 vaccine supplyJuan Camilo Castillo, Amrita Ahuja, Susan Athey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|May 14, 2016
CONFLICT. Reconciliation in Sierra LeoneKatherine Casey, Rachel Glennerster
Fortune|January 11, 2005
A magnet for vaccinesMichael Kremer, Rachel Glennerster
Science (New York, N.Y.)|April 20, 2013
The challenge of education and learning in the developing worldMichael Kremer, Conner Brannen, Rachel Glennerster
Plos One|November 2, 2016
Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled TrialShama Mohammed, Rachel Glennerster, Aamir J Khan
Journal of the European Economic Association|September 28, 2011
PUTTING A BAND-AID ON A CORPSE: INCENTIVES FOR NURSES IN THE INDIAN PUBLIC HEALTH CARE SYSTEMAbhijit V Banerjee, Rachel Glennerster, Esther Duflo
BMJ (Clinical Research Ed.)|May 19, 2010
Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentivesAbhijit Vinayak Banerjee, Esther Duflo, Rachel Glennerster, et al.
The American Economic Review|December 26, 2025
A Signal to End Child Marriage: Theory and Experimental Evidence from Bangladesh<sup>†</sup>Nina Buchmann, Erica Field, Rachel Glennerster, et al.
Eclinicalmedicine|July 5, 2022
Small mobile conditional cash transfers (mCCTs) of different amounts, schedules and design to improve routine childhood immunization coverage and timeliness of children aged 0-23 months in Pakistan: An open label multi-arm randomized controlled trialSubhash Chandir, Danya Arif Siddiqi, Sara Abdullah, et al.
Health Economics|October 3, 2006
Advance market commitments for vaccines against neglected diseases: estimating costs and effectivenessErnst R Berndt, Rachel Glennerster, Michael R Kremer, et al.
Science (New York, N.Y.)|February 26, 2021
Market design to accelerate COVID-19 vaccine supplyJuan Camilo Castillo, Amrita Ahuja, Susan Athey, et al.
Pageof 1